feed,title,long_url,short_url
Benzinga,European Commission approves SupemtekÂ® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older,https://www.benzinga.com/pressreleases/20/11/g18432426/european-commission-approves-supemtek-quadrivalent-recombinant-influenza-vaccine-for-the-preventio,https://j.mp/2KlOfow
